Table 9.
Selected Potential Patent Expirations in 2021
| Drug | Brand Name | Indication |
|---|---|---|
| Aprepitant oral suspension | Emend | Antinausea |
| Arformoterol | Brovana | COPD |
| Benzyl alcohol | Ulesfia | Antiparasite |
| Bupivacaine liposomal | Exparel | Anesthesia use |
| Degarelix | Firmagon | Prostate cancer |
| Emtricitabine | Emtriva | HIV infection |
| Everolimus | Afinitor | Pancreatic cancer |
| Ferumoxytol | Feraheme | Iron deficiency anemia |
| Formoterol | Performomist | COPD |
| Lopinovir/ritonavir | Kaletra | HIV infection |
| Magnesium sulfate anhydrous/ potassium sulfate/sodium sulfate | Suprep bowel prep kit | Bowel preparation |
| Naloxone nasal spray | Narcan | Counter effects of drug overdose |
| Nebivolol | Bystolic | Blood pressure control |
| Posaconazole oral suspension | Noxafil | Antifungal |
| Ritonovir | Norvir | HIV infection |
| Roflumilast | Daliresp | COPD |
| Sunitinib | Sutent | Cancer treatment |
| Ticagrelor | Brilinta | Anticoagulant |
| Varenicline | Chantix | Smoking prevention |
Abbreviations: COPD, chronic obstructive pulmonary disease; HIV, human immunodeficiency virus.